BioAmber Inc. (NYSE: BIOA) disclosed that on January 27th, 2017 BioAmber closed on its previously announced public offering of 4,236,844 units, including full exercise of underwriters’ option, at US $4.75 per unit for gross proceeds of US $20.1 million.
A portion of these securities was issued in Canada on a private placement basis. Rodman & Renshaw, a unit of H.C. Wainwright & Co., acted as the sole book-running manager in connection with this offering and AltaCorp Capital, Cormark Securities and Clarus Securities acted as co-managers.
BioAmber subsequently reimbursed its CDN $25 million or US $19.3 million loan with Bridging Finance Inc. Following the repayment of this loan, BioAmber has no corporate debt.
photo credit: BioAmber
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.
Latest posts by Ted Liu (see all)
- Drop announces US $44M Series B led by HOF Capital - August 22, 2019
- H1 2019 – Owen Bird and Torys leading law firms in exempt financing - August 21, 2019
- Intercap’s Docebo files for IPO on TSX - August 20, 2019